Overview A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension Status: Completed Trial end date: 2008-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine a safe and effective dose of ADX415 for the treatment of hypertension. Phase: Phase 2 Details Lead Sponsor: Addrenex Pharmaceuticals, Inc.